Testing nerve signals in gut samples from IBS patients
Part of Brain & nervous system, Digestive system clinical trials.
This study looks at how nerves behave in small gut tissue samples (biopsies) from people with irritable bowel syndrome (IBS) and healthy volunteers. The goal is to better understand IBS symptoms and what might be driving them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in one group: either IBS or a healthy control (no IBS symptoms).
- If you have IBS, your IBS diagnosis must match the Rome III symptom criteria.
- If you do not have IBS, you should not have IBS-related complaints.
- People who have bowel complaints that are not IBS are not eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how sensitive your gut is to normal stimuli in people with IBS, ulcerative colitis, Crohn’s disease, and in healthy volunteers. Results may help researchers understand why some people feel more abdominal discomfort and how that connects to inflammatory bowel conditions.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
This study uses small sensors placed on your belly to record electrical signals from your stomach and intestines. It may help doctors better understand conditions like Crohn's disease and other digestive issues without using needles or inside-the-body tests.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This study looks at how a medicine called UCB8600 affects certain immune cells (mast cells) in the gut. It is for people having colorectal cancer surgery and for patients with irritable bowel syndrome (IBS). The goal is to understand how the medicine works in the body and if it can help with IBS symptoms.
This study looks at stool (poop) samples to understand differences in gut bacteria in people with irritable bowel syndrome (IBS), depending on whether they’ve had treatment. It may help researchers find better ways to explain IBS and improve care.
Hear when a new IBS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.